Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2019.7332
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Complete Response to Systemic Treatment Might Predict Better Survival Rates Regardless of Their Metastatic Patterns in De Novo Stage IV Breast Cancer Patients Undergoing Primary Surgery

European Journal of Surgical Oncology
MedicineOncologySurgery
2020English

Assessing Tumor Heterogeneity Using ctDNA to Predict and Monitor Therapeutic Response in Metastatic Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2019English

De�novo Metastatic Breast Cancer: Subgroup Analysis of Molecular Subtypes and Prognosis

Oncology Letters
Cancer ResearchOncology
2020English

The Use of CT Findings to Predict Extent of Tumor at Primary Surgery for Ovarian Cancer

Obstetrical and Gynecological Survey
MedicineGynecologyObstetrics
2013English

Prognosis of Breast Cancer With Small Primary Tumor (Pt1)

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1991English

Activated Tumor-Infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients

Journal of Cancer
Oncology
2018English

Surgical Management of De Novo Stage IV Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Presence of Symptoms and Timing of Surgery Do Not Affect the Prognosis of Patients With Primary Metastatic Breast Cancer

European Journal of Surgical Oncology
MedicineOncologySurgery
2011English

A Method to Predict Breast Cancer Stage Using Medicare Claims

Epidemiologic Perspectives & Innovations
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy